Scroll to Top
Tackling the rise of counterfeit medicines
06 August 2012
A recent report published by the European Commission showed the growing threat of counterfeit medicines ordered over the internet – and industry bodies must work ...
Presentations from EFPIA 2012 Annual meetings now available online
19 July 2012
The public conference “Working Together for Europe’s Future” and the Educational Symposium “Healthcare Revolution with the New Science” took place on 27 June and aimed respectively to explore the ...
Announcement: Titta Rosvall-Puplett to be Acting Executive Director of EBE
03 July 2012
EFPIA announces the appointment of Titta Rosvall-Puplett as Acting Executive Director for EBE as from July 1, 2012. Titta joined EFPIA in 2009 as Director of Research ...
Antimicrobial resistance call launched
28 June 2012
IMI 6th Call 2012 - Stage 1 IMI has launched its Call for proposals on antimicrobial resistance. The deadline for submitting Expressions of Interest is 9 July 2012. The 6th Call 2012 ...
MEPs lead urgent plea from health community to prevent health crisis in Europe
25 June 2012
Media release – European Public Health Alliance (EPHA) Ahead of the European Summit of June (28-29), leading Members of the European Parliament (MEPs) joined a broad ...
Letter from EFPIA President, Sir Andrew Witty, to European Heads of States and Governments
25 June 2012
EU Growth Summit Innovation is vital to any successful long-term economic strategy. I am writing to ask that during the European Council in Brussels on 28-29 ...
Congratulating Elise Melon - Laureate - EFPIA College of Europe Award 2012
20 June 2012
"Patents, Competition Law and Open Innovation: A Study of "Global Patent Warming" (Thesis presented by Elise ...
Call for Tender - European Medicines Verification System (EMVS) (05/04/2012)
05 April 2012
Anti-counterfeiting measures on packaging such as holograms do already exist. But these can be copied, and therefore cannot provide an insurmountable barrier to counterfeiting of ...
UCB CEO to chair Innovative Medicines Initiative board (07/03/2012)
07 March 2012
The Innovative Medicines Initiative (IMI) announced today that Roch Doliveux, CEO of the biopharmaceutical company UCB, has been appointed Chairman of the Governing Board of ...
Joint Healthcare Industry Paper: The value of industry involvement in HTA (08/12/2011)
08 December 2011
What is the aim of HTA? According to the EUnetHTA definition1, health technology assessment (HTA) is a multidisciplinary process that summarises information about the medical, social, ...
Page 15 of 16
Press Releases & Statements
Enabling Technologies for Better Patient Outcomes - Live Streaming
Facts & Figures
Follow us on
Add us on
Check us out on
EFPIA Brussels Office
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
European Biopharmaceutical Enterprises
INNOVATIVE MEDICINES INITIATIVE
Educational Events & Ethical Evaluation
EFPIA 2017 - All rights reserved -
- Design by
Morris & Chapman